Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?
作者信息
Xia Yuguo, Cai Wei, Thomson Angus W, Hu Xiaoming
机构信息
Department of Neurology, University of Pittsburgh School of Medicine, 200 Lothrop Street, SBST 506, Pittsburgh, PA, 15213, USA.
Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
出版信息
Transl Stroke Res. 2016 Oct;7(5):415-9. doi: 10.1007/s12975-016-0476-4. Epub 2016 Jun 16.
Abstract
摘要
相似文献
1
Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?缺血性中风的调节性T细胞疗法：距离临床转化还有多远？
Transl Stroke Res. 2016 Oct;7(5):415-9. doi: 10.1007/s12975-016-0476-4. Epub 2016 Jun 16.
2
Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?缺血性中风的细胞治疗：临床前和临床研究设计的差异是否导致了疗效的转化损失？
Ann Neurol. 2019 Jul;86(1):5-16. doi: 10.1002/ana.25493. Epub 2019 May 8.
3
Interleukin-2 Mediated Expansion of T-Regulatory Cells as an Ischemic Stroke Therapy.白细胞介素-2介导的调节性T细胞扩增作为缺血性中风的一种治疗方法。
Stroke. 2024 Jun;55(6):e159-e160. doi: 10.1161/STROKEAHA.124.047357. Epub 2024 May 24.
4
Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.粒细胞集落刺激因子的不同治疗方案及其对实验性中风中 T 细胞特异性免疫反应的影响。
Immunol Lett. 2014 Mar-Apr;158(1-2):95-100. doi: 10.1016/j.imlet.2013.12.006. Epub 2013 Dec 12.
5
Sisyphus and translational stroke research.西西弗斯与转化卒中研究。
Sci Transl Med. 2012 Oct 17;4(156):156ps20. doi: 10.1126/scitranslmed.3005083.
6
Targeting lymphocytes in ischemic stroke.靶向缺血性卒中中的淋巴细胞。
World Neurosurg. 2011 Sep-Oct;76(3-4):212-4. doi: 10.1016/j.wneu.2011.06.060.
7
Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical.揭示罗塞塔石碑：首届关键要素转化中风治疗研究从临床前到临床年度会议报告。
Transl Stroke Res. 2018 Jun;9(3):258-266. doi: 10.1007/s12975-018-0628-9. Epub 2018 Apr 10.
8
Current Opinion of Bone Marrow Stromal Cell Transplantation for Ischemic Stroke.骨髓基质细胞移植治疗缺血性卒中的当前观点
Neurol Med Chir (Tokyo). 2016 Jun 15;56(6):293-301. doi: 10.2176/nmc.ra.2015-0349. Epub 2016 Mar 15.
9
Stem Cells as an Emerging Paradigm in Stroke 4: Advancing and Accelerating Preclinical Research.干细胞作为中风领域的新兴范例4：推进和加速临床前研究
Stroke. 2019 Nov;50(11):3299-3306. doi: 10.1161/STROKEAHA.119.025436. Epub 2019 Oct 17.
10
[Ischemic stroke--"time is brain"].缺血性中风——“时间就是大脑”
Anasthesiol Intensivmed Notfallmed Schmerzther. 2014 Jun;49(6):386-7. doi: 10.1055/s-0034-1383891. Epub 2014 Jul 8.
引用本文的文献
1
Regulatory T Cells for Stroke Recovery: A Promising Immune Therapeutic Strategy.用于中风恢复的调节性T细胞：一种有前景的免疫治疗策略。
CNS Neurosci Ther. 2025 Jan;31(1):e70248. doi: 10.1111/cns.70248.
2
GPR55 Inactivation Diminishes Splenic Responses and Improves Neurological Outcomes in the Mouse Ischemia/Reperfusion Stroke Model.GPR55 失活可减少小鼠脑缺血再灌注模型中的脾脏反应并改善神经功能结局。
Cells. 2024 Feb 3;13(3):280. doi: 10.3390/cells13030280.
3
Neuroinflammation and anti-inflammatory therapy for ischemic stroke.缺血性中风的神经炎症与抗炎治疗
Heliyon. 2023 Jul 6;9(7):e17986. doi: 10.1016/j.heliyon.2023.e17986. eCollection 2023 Jul.
4
Engineering of Immune Microenvironment for Enhanced Tissue Remodeling.免疫微环境工程增强组织重塑。
Tissue Eng Regen Med. 2022 Apr;19(2):221-236. doi: 10.1007/s13770-021-00419-z. Epub 2022 Jan 18.
5
IL-2/IL-2R Antibody Complex Enhances Treg-Induced Neuroprotection by Dampening TNF-α Inflammation in an In Vitro Stroke Model.白介素 2/白介素 2 受体抗体复合物通过抑制肿瘤坏死因子-α 炎症增强 Treg 诱导的神经保护作用在体外中风模型中。
Neuromolecular Med. 2021 Dec;23(4):540-548. doi: 10.1007/s12017-021-08656-0. Epub 2021 Apr 8.
6
Regulatory T cells in ischemic stroke.调节性 T 细胞与缺血性脑卒中。
Acta Pharmacol Sin. 2022 Jan;43(1):1-9. doi: 10.1038/s41401-021-00641-4. Epub 2021 Mar 26.
7
The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.那他丁醇对脑缺血模型小鼠调节性 T 细胞的影响。
J Neuroinflammation. 2021 Jan 30;18(1):37. doi: 10.1186/s12974-021-02083-5.
8
The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke.缺血性脑卒中后 T 细胞免疫反应及调节 T 辅助细胞水平的治疗靶点。
J Neuroinflammation. 2021 Jan 18;18(1):25. doi: 10.1186/s12974-020-02057-z.
9
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.利用调节性T细胞的神经保护活性治疗神经退行性疾病。
Mol Neurodegener. 2020 Jun 5;15(1):32. doi: 10.1186/s13024-020-00375-7.
10
Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.血脑屏障开放及代谢受损性脑血管缺血的机制，重点关注缺血性中风
Metab Brain Dis. 2020 Aug;35(6):851-868. doi: 10.1007/s11011-020-00573-8. Epub 2020 Apr 15.
本文引用的文献
1
Regulatory T Cells in Post-stroke Immune Homeostasis.中风后免疫稳态中的调节性T细胞
Transl Stroke Res. 2016 Aug;7(4):313-21. doi: 10.1007/s12975-016-0465-7. Epub 2016 Mar 31.
2
Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.共病对临床前卒中研究中急性损伤和恢复的影响：聚焦高血压和糖尿病
Transl Stroke Res. 2016 Aug;7(4):248-60. doi: 10.1007/s12975-016-0464-8. Epub 2016 Mar 30.
3
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.共生微生物群通过调节肠道γδ T细胞影响缺血性中风的预后。
Nat Med. 2016 May;22(5):516-23. doi: 10.1038/nm.4068. Epub 2016 Mar 28.
4
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.一项基于调节性 T 细胞的细胞治疗用于活体肝移植中获得免疫耐受的初步研究。
Hepatology. 2016 Aug;64(2):632-43. doi: 10.1002/hep.28459. Epub 2016 Mar 10.
5
Type 1 diabetes immunotherapy using polyclonal regulatory T cells.使用多克隆调节性T细胞的1型糖尿病免疫疗法。
Sci Transl Med. 2015 Nov 25;7(315):315ra189. doi: 10.1126/scitranslmed.aad4134.
6
Decade in review-stroke: progress in acute ischaemic stroke treatment and prevention.十年回顾——中风：急性缺血性中风治疗与预防的进展
Nat Rev Neurol. 2015 Nov;11(11):619-21. doi: 10.1038/nrneurol.2015.199. Epub 2015 Oct 20.
7
Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10.活化的调节性T细胞通过白细胞介素10调节正常和缺血小鼠脑室下区神经干细胞的增殖。
Front Cell Neurosci. 2015 Sep 14;9:361. doi: 10.3389/fncel.2015.00361. eCollection 2015.
8
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.用激动性DR3抗体治疗可导致供体调节性T细胞扩增并减轻移植物抗宿主病。
Blood. 2015 Jul 23;126(4):546-57. doi: 10.1182/blood-2015-04-637587. Epub 2015 Jun 10.
9
White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke.白质损伤和小胶质细胞/巨噬细胞极化与中风后与年龄相关的长期神经功能缺陷密切相关。
Exp Neurol. 2015 Oct;272:109-19. doi: 10.1016/j.expneurol.2015.03.021. Epub 2015 Mar 31.
10
Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.雷帕霉素与FLT3配体之间的协同作用增强了浆细胞样树突状细胞依赖性的CD4+CD25+FoxP3+调节性T细胞的诱导。
Blood. 2015 May 7;125(19):2937-47. doi: 10.1182/blood-2014-09-599266. Epub 2015 Apr 1.
Zotero 插件